Economics of influenza vaccine administration timing for children.

Bruce Lee, Julie H Y Tai, Rachel R. Bailey, Kenneth J. Smith, Andrew J. Nowalk

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: To determine how much should be invested each year to encourage and operationalize the administration of influenza vaccine to children before November and how late the vaccine should be offered each year. STUDY DESIGN: Monte Carlo decision analytic computer simulation models. METHODS: The children's influenza vaccination timing model quantified the incremental economic value of vaccinating a child earlier in the influenza season and the incremental cost of delaying vaccination. The children's monthly influenza vaccination decision model evaluated the cost-effectiveness of vaccinating versus not vaccinating for every month of the influenza season. RESULTS: Getting children vaccinated by the end of October rather than when they are currently getting vaccinated could save society between $6.4 million and $9.2 million plus 653 and 926 quality-adjusted life-years (QALYs) and third-party payers between $4.1 million and $6.1 million plus 647 to 942 QALYs each year. Decision makers may want to continue offering influenza vaccination to children at least through the end of December. Vaccinating with trivalent inactivated virus vaccine was more cost-effective than vaccinating with live attenuated influenza vaccine for every month. CONCLUSION: Policymakers could invest up to $6 million to $9 million a year to get children vaccinated in September or October without expending any net costs.

Original languageEnglish (US)
JournalAmerican Journal of Managed Care
Volume16
Issue number3
StatePublished - Mar 2010
Externally publishedYes

Fingerprint

Influenza Vaccines
Economics
Human Influenza
Vaccination
Quality-Adjusted Life Years
Costs and Cost Analysis
Computer Simulation
Health Insurance Reimbursement
Attenuated Vaccines
Inactivated Vaccines
Cost-Benefit Analysis
Vaccines
Viruses

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lee, B., Tai, J. H. Y., Bailey, R. R., Smith, K. J., & Nowalk, A. J. (2010). Economics of influenza vaccine administration timing for children. American Journal of Managed Care, 16(3).

Economics of influenza vaccine administration timing for children. / Lee, Bruce; Tai, Julie H Y; Bailey, Rachel R.; Smith, Kenneth J.; Nowalk, Andrew J.

In: American Journal of Managed Care, Vol. 16, No. 3, 03.2010.

Research output: Contribution to journalArticle

Lee, B, Tai, JHY, Bailey, RR, Smith, KJ & Nowalk, AJ 2010, 'Economics of influenza vaccine administration timing for children.', American Journal of Managed Care, vol. 16, no. 3.
Lee, Bruce ; Tai, Julie H Y ; Bailey, Rachel R. ; Smith, Kenneth J. ; Nowalk, Andrew J. / Economics of influenza vaccine administration timing for children. In: American Journal of Managed Care. 2010 ; Vol. 16, No. 3.
@article{e5e15b7645e04846a463ad3155f5b9eb,
title = "Economics of influenza vaccine administration timing for children.",
abstract = "OBJECTIVES: To determine how much should be invested each year to encourage and operationalize the administration of influenza vaccine to children before November and how late the vaccine should be offered each year. STUDY DESIGN: Monte Carlo decision analytic computer simulation models. METHODS: The children's influenza vaccination timing model quantified the incremental economic value of vaccinating a child earlier in the influenza season and the incremental cost of delaying vaccination. The children's monthly influenza vaccination decision model evaluated the cost-effectiveness of vaccinating versus not vaccinating for every month of the influenza season. RESULTS: Getting children vaccinated by the end of October rather than when they are currently getting vaccinated could save society between $6.4 million and $9.2 million plus 653 and 926 quality-adjusted life-years (QALYs) and third-party payers between $4.1 million and $6.1 million plus 647 to 942 QALYs each year. Decision makers may want to continue offering influenza vaccination to children at least through the end of December. Vaccinating with trivalent inactivated virus vaccine was more cost-effective than vaccinating with live attenuated influenza vaccine for every month. CONCLUSION: Policymakers could invest up to $6 million to $9 million a year to get children vaccinated in September or October without expending any net costs.",
author = "Bruce Lee and Tai, {Julie H Y} and Bailey, {Rachel R.} and Smith, {Kenneth J.} and Nowalk, {Andrew J.}",
year = "2010",
month = "3",
language = "English (US)",
volume = "16",
journal = "American Journal of Managed Care",
issn = "1088-0224",
publisher = "Ascend Media",
number = "3",

}

TY - JOUR

T1 - Economics of influenza vaccine administration timing for children.

AU - Lee, Bruce

AU - Tai, Julie H Y

AU - Bailey, Rachel R.

AU - Smith, Kenneth J.

AU - Nowalk, Andrew J.

PY - 2010/3

Y1 - 2010/3

N2 - OBJECTIVES: To determine how much should be invested each year to encourage and operationalize the administration of influenza vaccine to children before November and how late the vaccine should be offered each year. STUDY DESIGN: Monte Carlo decision analytic computer simulation models. METHODS: The children's influenza vaccination timing model quantified the incremental economic value of vaccinating a child earlier in the influenza season and the incremental cost of delaying vaccination. The children's monthly influenza vaccination decision model evaluated the cost-effectiveness of vaccinating versus not vaccinating for every month of the influenza season. RESULTS: Getting children vaccinated by the end of October rather than when they are currently getting vaccinated could save society between $6.4 million and $9.2 million plus 653 and 926 quality-adjusted life-years (QALYs) and third-party payers between $4.1 million and $6.1 million plus 647 to 942 QALYs each year. Decision makers may want to continue offering influenza vaccination to children at least through the end of December. Vaccinating with trivalent inactivated virus vaccine was more cost-effective than vaccinating with live attenuated influenza vaccine for every month. CONCLUSION: Policymakers could invest up to $6 million to $9 million a year to get children vaccinated in September or October without expending any net costs.

AB - OBJECTIVES: To determine how much should be invested each year to encourage and operationalize the administration of influenza vaccine to children before November and how late the vaccine should be offered each year. STUDY DESIGN: Monte Carlo decision analytic computer simulation models. METHODS: The children's influenza vaccination timing model quantified the incremental economic value of vaccinating a child earlier in the influenza season and the incremental cost of delaying vaccination. The children's monthly influenza vaccination decision model evaluated the cost-effectiveness of vaccinating versus not vaccinating for every month of the influenza season. RESULTS: Getting children vaccinated by the end of October rather than when they are currently getting vaccinated could save society between $6.4 million and $9.2 million plus 653 and 926 quality-adjusted life-years (QALYs) and third-party payers between $4.1 million and $6.1 million plus 647 to 942 QALYs each year. Decision makers may want to continue offering influenza vaccination to children at least through the end of December. Vaccinating with trivalent inactivated virus vaccine was more cost-effective than vaccinating with live attenuated influenza vaccine for every month. CONCLUSION: Policymakers could invest up to $6 million to $9 million a year to get children vaccinated in September or October without expending any net costs.

UR - http://www.scopus.com/inward/record.url?scp=77952309805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952309805&partnerID=8YFLogxK

M3 - Article

C2 - 20205492

AN - SCOPUS:77952309805

VL - 16

JO - American Journal of Managed Care

JF - American Journal of Managed Care

SN - 1088-0224

IS - 3

ER -